SCHEMBL7375871

SCHEMBL7375871

O=C(O)CCN1CNc2c1nc[nH]c2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 7/20 0.58
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
KDM4E B2RXH2 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
ESR1 P03372 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768185 0.86 HPRT1 (0.54) HPRT1KDM4ETSHRHSD17B10KMT2A
SCHEMBL2913487 0.82 HPRT1 (0.59) HPRT1PDE4APDE4BPDE4CPDE4D
SCHEMBL930873 0.79 HPRT1 (0.47) HPRT1HSD17B10MEN1KMT2APOLB
Water SCHEMBL6931313 0.79 HPRT1 (0.46) HPRT1HSD17B10MEN1KMT2APOLB
Hydrochloric Acid SCHEMBL6935179 0.79 HPRT1 (0.46) HPRT1HSD17B10MEN1KMT2APOLB
SCHEMBL7684221 0.78 HPRT1 (0.45) HPRT1KDM4EKMT2ASMN1; SMN2
Potassium Ion SCHEMBL6932912 0.75 HPRT1 (0.45) HPRT1MEN1KMT2APOLBMAPT
SCHEMBL5250159 0.74 HPRT1 (0.60) HPRT1APEX1
SCHEMBL931907 0.73 MAPT (0.43) HPRT1KDM4EALOX15HSD17B10MEN1
SCHEMBL7061691 0.73 HPRT1 (0.59) HPRT1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303617-B1 FOR THERAPY OF OBESITY, LOWERING SERUM CHOLESTEROL AND HIGH DENSITY LIPOPROTEIN IN MAMMALS, INHIBITOR OF MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-16 US disclosed
WO-1999057120-A9 NOVEL SEROTONIN-LIKE 9-SUBSTITUTED HYPOXANTHINE AND METHODS OF USE NEOTHERAPEUTICS INC (US) 2000-02-03 WO disclosed
WO-1999057119-A1 NOVEL DOPAMINE-LIKE 9-SUBSTITUTED HYPOXANTHINE AND METHODS OF USE NEOTHERAPEUTICS, INC. (US) 1999-11-11 WO disclosed
WO-1999057120-A1 NOVEL SEROTONIN-LIKE 9-SUBSTITUTED HYPOXANTHINE AND METHODS OF USE NEOTHERAPEUTICS, INC. (US) 1999-11-11 WO disclosed
WO-1999056550-A1 METHOD FOR TREATING MIGRAINE IN MAMMALS NEOTHERAPEUTICS, INC. (US) 1999-11-11 WO disclosed